PCI Pharma Services has acquired Ajinomoto Althea, Inc., a US-based sterile fill-finish CDMO and subsidiary of Japan-based ...

PCI Pharma Services is acquiring an entire equity stake in Ajinomoto Althea Inc. (Althea), a U.S.-based sterile fill-finish ...

It could vastly expand their use in drug delivery, including by Tiny Cargo ... Other labs had tried freeze-drying, technically known as lyophilization, but with limited success.

PCI Pharma Services ("PCI") – a leading global contract development and manufacturing organization (CDMO) focused on ...

Along with PCI's own robust infrastructure expansions, acquisition furthers CDMO's recent growth in sterile fill-finish, advanced drug delivery ...

Lyophilization is one of the most time-consuming and expensive operations, and improved drying technologies are required for current and future products. 16% of the top 100 pharmaceutical drugs ...

Meribel Pharma has established centers of excellence in drug development, lyophilization, and preservative-free multidose technologies.

The acquisition also adds high potent vial filling with lyophilization, making PCI one of very few US-based CDMOs capable of producing the emerging oncology modality of antibody-drug conjugates ...

Acquisition creates a world-class large-scale manufacturing hub in San Diego region with state-of-the-art aseptic facilities ...

The increasing adoption of biologic and biosimilar drugs for complex diseases like ... The funds raised were intended to enhance vial, lyophilization, and suspension capacity, as well as to ...

The increasing adoption of biologic and biosimilar drugs for complex diseases like cancer and autoimmune ... The funds raised were intended to enhance vial, lyophilization, and suspension capacity, as ...

The FDA has approved a ready-to-dilute, multi-dose formulation of thiotepa (Tepylute) for use in breast and ovarian ...